Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.

Jerold LohJiaxuan WuJenny ChiengAurora ChanWei-Peng YongRaghav SundarSoo-Chin LeeAndrea WongJoline S J LimDavid S P TanRoss SooBoon-Cher GohBee-Choo TaiCheng Ean Chee

Published in: British journal of cancer (2023)

We developed a NCIS prognostic score with excellent prognostic ability for both short-term and longer-term survival (iAUC: 0.71 [95% CI 0.65-0.76]), and validated the RMH model in the largest Asian study to date.

Keyphrases

prognostic factors
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
preterm infants
patient reported outcomes
study protocol
patient reported